Learn more about Bristol-Myers Squibb Company's Revenue by Segment and Revenue by Region.
Check out competitors to Bristol-Myers Squibb Company in a side-by-side comparison.
Explore additional financial metrics for Bristol-Myers Squibb Company.
| 2015 | 16560000000.00 |
|---|---|
| 2016 | 19427000000.00 |
| 2017 | 20776000000.00 |
| 2018 | 22561000000.00 |
| 2019 | 26145000000.00 |
| 2020 | 42518000000.00 |
| 2021 | 46385000000.00 |
| 2022 | 46159000000.00 |
| 2023 | 45006000000.00 |
| 2024 | 48300000000.00 |
| 2025 | 48194000000.00 |
| Mar 2016 | 4391000000.00 |
|---|---|
| Jun 2016 | 4871000000.00 |
| Sep 2016 | 4922000000.00 |
| Dec 2016 | 5243000000.00 |
| Mar 2017 | 4929000000.00 |
| Jun 2017 | 5144000000.00 |
| Sep 2017 | 5254000000.00 |
| Dec 2017 | 5449000000.00 |
| Mar 2018 | 5193000000.00 |
| Jun 2018 | 5704000000.00 |
| Sep 2018 | 5691000000.00 |
| Dec 2018 | 5973000000.00 |
| Mar 2019 | 5920000000.00 |
| Jun 2019 | 6273000000.00 |
| Sep 2019 | 6007000000.00 |
| Dec 2019 | 7945000000.00 |
| Mar 2020 | 10781000000.00 |
| Jun 2020 | 10129000000.00 |
| Sep 2020 | 10540000000.00 |
| Dec 2020 | 11068000000.00 |
| Mar 2021 | 11073000000.00 |
| Jun 2021 | 11703000000.00 |
| Sep 2021 | 11624000000.00 |
| Dec 2021 | 11985000000.00 |
| Mar 2022 | 11648000000.00 |
| Jun 2022 | 11887000000.00 |
| Sep 2022 | 11218000000.00 |
| Dec 2022 | 11406000000.00 |
| Mar 2023 | 11337000000.00 |
| Jun 2023 | 11226000000.00 |
| Sep 2023 | 10966000000.00 |
| Dec 2023 | 11477000000.00 |
| Mar 2024 | 11865000000.00 |
| Jun 2024 | 12201000000.00 |
| Sep 2024 | 11892000000.00 |
| Dec 2024 | 12342000000.00 |
| Mar 2025 | 11201000000.00 |
| Jun 2025 | 12269000000.00 |
| Sep 2025 | 12222000000.00 |
| Dec 2025 | 12502000000.00 |
| Mar 2026 | 11489000000.00 |
Bristol-Myers Squibb Company's annual revenue was $48.19 B in fiscal year 2025.
Bristol-Myers Squibb Company's quarterly revenue was $11.20 B(Q1: Mar 2025), $12.27 B(Q2: Jun 2025), $12.22 B(Q3: Sep 2025), $12.50 B(Q4: Dec 2025) in fiscal year 2025.
Bristol-Myers Squibb Company's annual revenue was $48.30 B in fiscal year 2024.
Bristol-Myers Squibb Company's quarterly revenue was $11.87 B(Q1: Mar 2024), $12.20 B(Q2: Jun 2024), $11.89 B(Q3: Sep 2024), $12.34 B(Q4: Dec 2024) in fiscal year 2024.
Bristol-Myers Squibb Company's annual revenue was $45.01 B in fiscal year 2023.
Bristol-Myers Squibb Company's quarterly revenue was $11.34 B(Q1: Mar 2023), $11.23 B(Q2: Jun 2023), $10.97 B(Q3: Sep 2023), $11.48 B(Q4: Dec 2023) in fiscal year 2023.
Bristol-Myers Squibb Company's annual revenue was $46.16 B in fiscal year 2022.
Bristol-Myers Squibb Company's quarterly revenue was $11.65 B(Q1: Mar 2022), $11.89 B(Q2: Jun 2022), $11.22 B(Q3: Sep 2022), $11.41 B(Q4: Dec 2022) in fiscal year 2022.
Bristol-Myers Squibb Company's annual revenue was $46.39 B in fiscal year 2021.
Bristol-Myers Squibb Company's quarterly revenue was $11.07 B(Q1: Mar 2021), $11.70 B(Q2: Jun 2021), $11.62 B(Q3: Sep 2021), $11.99 B(Q4: Dec 2021) in fiscal year 2021.
Bristol-Myers Squibb Company's annual revenue was $42.52 B in fiscal year 2020.
Bristol-Myers Squibb Company's quarterly revenue was $10.78 B(Q1: Mar 2020), $10.13 B(Q2: Jun 2020), $10.54 B(Q3: Sep 2020), $11.07 B(Q4: Dec 2020) in fiscal year 2020.
Bristol-Myers Squibb Company's annual revenue was $26.15 B in fiscal year 2019.
Bristol-Myers Squibb Company's quarterly revenue was $5.92 B(Q1: Mar 2019), $6.27 B(Q2: Jun 2019), $6.01 B(Q3: Sep 2019), $7.95 B(Q4: Dec 2019) in fiscal year 2019.
Bristol-Myers Squibb Company's annual revenue was $22.56 B in fiscal year 2018.
Bristol-Myers Squibb Company's quarterly revenue was $5.19 B(Q1: Mar 2018), $5.70 B(Q2: Jun 2018), $5.69 B(Q3: Sep 2018), $5.97 B(Q4: Dec 2018) in fiscal year 2018.
Bristol-Myers Squibb Company's annual revenue was $20.78 B in fiscal year 2017.
Bristol-Myers Squibb Company's quarterly revenue was $4.93 B(Q1: Mar 2017), $5.14 B(Q2: Jun 2017), $5.25 B(Q3: Sep 2017), $5.45 B(Q4: Dec 2017) in fiscal year 2017.
Bristol-Myers Squibb Company's annual revenue was $19.43 B in fiscal year 2016.
Bristol-Myers Squibb Company's quarterly revenue was $4.39 B(Q1: Mar 2016), $4.87 B(Q2: Jun 2016), $4.92 B(Q3: Sep 2016), $5.24 B(Q4: Dec 2016) in fiscal year 2016.
| 2015 | 0 |
|---|---|
| 2016 | +17.31 |
| 2017 | +6.94 |
| 2018 | +8.59 |
| 2019 | +15.89 |
| 2020 | +62.62 |
| 2021 | +9.09 |
| 2022 | -0.49 |
| 2023 | -2.50 |
| 2024 | +7.32 |
| 2025 | -0.22 |
| Q1: Mar 16 | 8.66 |
|---|---|
| Q2: Jun 16 | 17.01 |
| Q3: Sep 16 | 20.96 |
| Q4: Dec 16 | 22.30 |
| Q1: Mar 17 | 12.25 |
| Q2: Jun 17 | 5.60 |
| Q3: Sep 17 | 6.75 |
| Q4: Dec 17 | 3.93 |
| Q1: Mar 18 | 5.36 |
| Q2: Jun 18 | 10.89 |
| Q3: Sep 18 | 8.32 |
| Q4: Dec 18 | 9.62 |
| Q1: Mar 19 | 14.00 |
| Q2: Jun 19 | 9.98 |
| Q3: Sep 19 | 5.55 |
| Q4: Dec 19 | 33.02 |
| Q1: Mar 20 | 82.11 |
| Q2: Jun 20 | 61.47 |
| Q3: Sep 20 | 75.46 |
| Q4: Dec 20 | 39.31 |
| Q1: Mar 21 | 2.71 |
| Q2: Jun 21 | 15.54 |
| Q3: Sep 21 | 10.28 |
| Q4: Dec 21 | 8.29 |
| Q1: Mar 22 | 5.19 |
| Q2: Jun 22 | 1.57 |
| Q3: Sep 22 | -3.49 |
| Q4: Dec 22 | -4.83 |
| Q1: Mar 23 | -2.67 |
| Q2: Jun 23 | -5.56 |
| Q3: Sep 23 | -2.25 |
| Q4: Dec 23 | 0.62 |
| Q1: Mar 24 | 4.66 |
| Q2: Jun 24 | 8.69 |
| Q3: Sep 24 | 8.44 |
| Q4: Dec 24 | 7.54 |
| Q1: Mar 25 | -5.60 |
| Q2: Jun 25 | 0.56 |
| Q3: Sep 25 | 2.77 |
| Q4: Dec 25 | 1.30 |
| Q1: Mar 26 | 2.57 |
Bristol-Myers Squibb Company’s annual revenue decreased -0.22% during fiscal year 2025 compared to 2024. It represents a decline of $106.00 M from $48.30 B (in 2024) to $48.19 B (in 2025).
Bristol-Myers Squibb Company’s annual revenue increased +7.32% during fiscal year 2024 compared to 2023. It represents a growth of $3.29 B from $45.01 B (in 2023) to $48.30 B (in 2024).
Bristol-Myers Squibb Company’s annual revenue decreased -2.50% during fiscal year 2023 compared to 2022. It represents a decline of $1.15 B from $46.16 B (in 2022) to $45.01 B (in 2023).
Bristol-Myers Squibb Company’s annual revenue decreased -0.49% during fiscal year 2022 compared to 2021. It represents a decline of $226.00 M from $46.39 B (in 2021) to $46.16 B (in 2022).
Bristol-Myers Squibb Company’s annual revenue increased +9.09% during fiscal year 2021 compared to 2020. It represents a growth of $3.87 B from $42.52 B (in 2020) to $46.39 B (in 2021).
Bristol-Myers Squibb Company’s annual revenue increased +62.62% during fiscal year 2020 compared to 2019. It represents a growth of $16.37 B from $26.15 B (in 2019) to $42.52 B (in 2020).
Bristol-Myers Squibb Company’s annual revenue increased +15.89% during fiscal year 2019 compared to 2018. It represents a growth of $3.58 B from $22.56 B (in 2018) to $26.15 B (in 2019).
Bristol-Myers Squibb Company’s annual revenue increased +8.59% during fiscal year 2018 compared to 2017. It represents a growth of $1.79 B from $20.78 B (in 2017) to $22.56 B (in 2018).
Bristol-Myers Squibb Company’s annual revenue increased +6.94% during fiscal year 2017 compared to 2016. It represents a growth of $1.35 B from $19.43 B (in 2016) to $20.78 B (in 2017).
Bristol-Myers Squibb Company’s annual revenue increased +17.31% during fiscal year 2016 compared to 2015. It represents a growth of $2.87 B from $16.56 B (in 2015) to $19.43 B (in 2016).
Sign in to download table
| Period | Revenue | Year-over-Year Change |
|---|---|---|
|
Get instant access to data, Sign up for free
FY 2025
|
$48.19 B |
-$106.00 M
|
| Q4: Dec 25 | $12.50 B |
$160.00 M
|
| Q3: Sep 25 | $12.22 B |
$330.00 M
|
| Q2: Jun 25 | $12.27 B |
$68.00 M
|
| Q1: Mar 25 | $11.20 B |
-$664.00 M
|
|
Get instant access to data, Sign up for free
FY 2024
|
$48.30 B |
$3.29 B
|
| Q4: Dec 24 | $12.34 B |
$865.00 M
|
| Q3: Sep 24 | $11.89 B |
$926.00 M
|
| Q2: Jun 24 | $12.20 B |
$975.00 M
|
| Q1: Mar 24 | $11.87 B |
$528.00 M
|
|
Get instant access to data, Sign up for free
FY 2023
|
$45.01 B |
-$1.15 B
|
| Q4: Dec 23 | $11.48 B |
$71.00 M
|
| Q3: Sep 23 | $10.97 B |
-$252.00 M
|
| Q2: Jun 23 | $11.23 B |
-$661.00 M
|
| Q1: Mar 23 | $11.34 B |
-$311.00 M
|
|
Get instant access to data, Sign up for free
FY 2022
|
$46.16 B |
-$226.00 M
|
| Q4: Dec 22 | $11.41 B |
-$579.00 M
|
| Q3: Sep 22 | $11.22 B |
-$406.00 M
|
| Q2: Jun 22 | $11.89 B |
$184.00 M
|
| Q1: Mar 22 | $11.65 B |
$575.00 M
|
|
Get instant access to data, Sign up for free
FY 2021
|
$46.39 B |
$3.87 B
|
| Q4: Dec 21 | $11.99 B |
$917.00 M
|
| Q3: Sep 21 | $11.62 B |
$1.08 B
|
| Q2: Jun 21 | $11.70 B |
$1.57 B
|
| Q1: Mar 21 | $11.07 B |
$292.00 M
|
|
Get instant access to data, Sign up for free
FY 2020
|
$42.52 B |
$16.37 B
|
| Q4: Dec 20 | $11.07 B |
$3.12 B
|
| Q3: Sep 20 | $10.54 B |
$4.53 B
|
| Q2: Jun 20 | $10.13 B |
$3.86 B
|
| Q1: Mar 20 | $10.78 B |
$4.86 B
|
|
Get instant access to data, Sign up for free
FY 2019
|
$26.15 B |
$3.58 B
|
| Q4: Dec 19 | $7.95 B |
$1.97 B
|
| Q3: Sep 19 | $6.01 B |
$316.00 M
|
| Q2: Jun 19 | $6.27 B |
$569.00 M
|
| Q1: Mar 19 | $5.92 B |
$727.00 M
|
|
Get instant access to data, Sign up for free
FY 2018
|
$22.56 B |
$1.79 B
|
| Q4: Dec 18 | $5.97 B |
$524.00 M
|
| Q3: Sep 18 | $5.69 B |
$437.00 M
|
| Q2: Jun 18 | $5.70 B |
$560.00 M
|
| Q1: Mar 18 | $5.19 B |
$264.00 M
|
|
Get instant access to data, Sign up for free
FY 2017
|
$20.78 B |
$1.35 B
|
| Q4: Dec 17 | $5.45 B |
$206.00 M
|
| Q3: Sep 17 | $5.25 B |
$332.00 M
|
| Q2: Jun 17 | $5.14 B |
$273.00 M
|
| Q1: Mar 17 | $4.93 B |
$538.00 M
|
|
Get instant access to data, Sign up for free
FY 2016
|
$19.43 B |
$2.87 B
|
| Q4: Dec 16 | $5.24 B |
$956.00 M
|
| Q3: Sep 16 | $4.92 B |
$853.00 M
|
| Q2: Jun 16 | $4.87 B |
$708.00 M
|
| Q1: Mar 16 | $4.39 B |
$350.00 M
|
In fiscal year 2025, Bristol-Myers Squibb Company's revenue was $48.19 Billion.
Bristol-Myers Squibb Company's revenue decreased by -0.22% (-$106.00 Million) in 2025 compared to 2024.
In the first quarter (Q1) of 2026, Bristol-Myers Squibb Company reported a revenue of $11.49 Billion.
Bristol-Myers Squibb Company's revenue per share over the trailing twelve months is $23.72.
In the fiscal year 2025, Bristol-Myers Squibb Company's revenue per employee was $1.48 Million.
In fiscal year 2025, Bristol-Myers Squibb Company's net income was $7.05 Billion.
Eliquis is Bristol-Myers Squibb Company's biggest product segment, generating $14.44 Billion in revenue for fiscal year 2025.
In the fiscal year 2025, Bristol-Myers Squibb Company's net income per employee was $217.02 K.